HOME   NEWS   BLOG   MEDIA   CAREERS   CONTACT US
The Spectrum Blog

Enter your email address to subscribe to this blog:

Add to Google
Subscribe in Bloglines

Lost No Longer: Your Guide to Navigate Global Pharma Marketing Regulations is Here

April 7th, 2008

Not quite three weeks ago in this blog, I hinted at the announcement of a "pretty cool" information tool that we developed through Spectrum's partnership in GLOBALHealthPR.

If you're a global pharma marketing director or product communications manager, how do you keep all the regulatory do's and don't's straight, from Japan to Germany? What if somebody collected it all and published one simple guidebook?

Ooops, we just did it. And not again, but for the first time.

Ladies and gentleman, today's the premiere of The Global Guide to Pharma Marketing Codes, the first-ever compendium that reviews the widely varying guidelines to prescription drug marketing in major international markets.

Click here for a preview.

, , ,

Architecture of Health Care in the Capitol®

March 20th, 2008

The Public Affairs team just launched Health Care in the Capitol®, a monthly e-newsletter that keeps pace with the rapidly changing landscape of health care policy on Capitol Hill. With Health Care in the Capitol®, we will be an intelligent aggregator and editor of news with a keen outlook as to what's gaining traction among legislators and their staff. If you're strapped for time and not interested in poring through reams of language to find out what developments will speak to you and your business, Health Care in the Capitol® will become your "go to" resource.

We'll make Health Care in the Capitol® easy to navigate, interactive and engaging. We won't be using just articles to tell the stories, but video, audio, links to credible blogs and graphics - it's a fusion of health care news and digital media. To check out our inaugural issue, click here.

Coming up with content is the easy part - but anyone in communications knows it's all about creating a name or brand that stands apart. After much discourse, "Health Care in the Capitol" was suggested. We knew our readers would wonder, since we are located in Washington, aren't we talking about the nation's capital, as in the town? Or, are we referring to the Capitol, a campus of chambers and caucuses, Congressmen and corridors? Finally, after much back and forth, we decided to use "Capitol." In true form, we agreed that the newsletter, though reported from the nation's capital, is about the activity of the Capitol complex and the policy discussions, political debates and competing punditry that fill its halls.

We hope you will join us from the nation's capital as we distribute information and seek creative, innovative ways to communicate the legislative activities on Capitol Hill.

Cap•i•tol [kap-i-tl] n.
The building in Washington, D.C. where the U.S. Congress meets. Designed by self-taught architect, Dr. William Thornton, in 1792. A complex that includes Senate and House office buildings, the Supreme Court, the Library of Congress and more. A campus that is central to the implementation of law, policy and a place that guides the national rhetoric of democratic politics.

Cap•i•tal [kap-i-tl] n.
The city or town that is the official seat of government in a country, state, etc. Ex: Washington is the capital of the U.S.

-Erica Anderson, Account Executive

, , ,

Mapping a Better Way, Internationally

March 18th, 2008
Last week, principals of leading independent public relations firms from nine countries spanning four continents gathered in Tokyo to share our expertise in health communications and to contrast health consumer and trade media characteristics between Japan and the US/Europe. We also shared with about 20 execs from Japan's most prestigious pharma companies the fundamentals of contemporary pharma marketing from a very tough Western world perspective right now.

Our organization is GLOBALHealthPR, and we're the largest independent public relations organization dedicated exclusively to healthcare communications worldwide. Spectrum was a founder.

I must acknowledge our friends at LBS Co. for graciously hosting the press conference, the pharma industry seminar and our annual meeting. Media who attended the press conference included the Yomiuri Shimbun, the largest newspaper in the world at more than 14,000,000 combined circulation for morning and evening editions; Japan Broadcasting Corporation, and Japan Medical Journal.

Since our meeting, we've announced the selection of Aurora, a London-based health-only communications firm, as our new UK partner. Click for more information about Aurora and GLOBALHealthPR.

Watch this space in the next several weeks for the announcement of a pretty cool pharma marketing tool developed by GLOBALHealthPR.

-John Seng, Founder and President

, , ,

Green Environment- For TB That Is

February 29th, 2008

I noted with interest and concern the recent news that new, highly resistant strains of tuberculosis threaten populations around the world, particularly in Eastern Europe (5% of TB Cases Don't React to Some Drugs). A day earlier, the AP reported findings that "drug-resistant tuberculosis is spreading even faster than medical experts had feared." (WHO Says Drug-Resistant TB Spreads Fast) Is it only a matter of time until these cutting-edge strains find their way ashore the US? Actually, these wildcat threats are already here and more are just a transatlantic plane ride away.

For a glimmer of hope, elsewhere this week came news of innovation in treating bacterial infections (Synthetic bacteria-fighting organisms win Lemelson-MIT prize), thanks to an intrepid as well as incentivized 27-year old student from MIT who won a prize for devising a method for cultivating a new type of virus called a bacteriophage that would directly attack tuberculosis and other bacteria.

Readers of all these articles might conclude that the best hope against TB globally is wellsprings of wisdom such as MIT research contests. However, a "eureka" moment of discovery is only the beginning of the equation. The real promise in fully developing safe and effective treatments and even cures for killing diseases comes true with natural economic incentives to industry offered by the only two somewhat free markets that survive worldwide - the US and New Zealand. The health systems of all other countries want either patented drugs at little to no premium or no patent protections on pharmaceuticals at all.

Advantage TB, and lots of other killing diseases.

New strains are here with more en route. Seems TB is discovering a more hospitable environment for growth worldwide than pharmaceutical researchers and their employers.

-John Seng, Founder and President

, , ,

If It Works, Support It!

February 20th, 2008

It’s been a while since I’ve blogged, and for this transgression, you have my deepest apologies. It took some pretty dramatic, positive news to break my logjam, but this morning’s news (WASHINGTON POST - US Cancer Death Rate Down) about the decline in cancer death rates did the trick.

The nation’s cancer research leadership needs to leverage these good findings from the American Cancer Society and continue pressuring Congress to increase funding for the National Cancer Institute. Today’s coverage cites double digit declines in cancer death rates for both women and men from 1990 through 2005. The irony is that since 2005, federal cancer research funding levels have been effectively frozen in time, increasing at the annual rate of 0.0275 percent, or less than three-hundredths of one percent! (Is that even statistically significant?)

We make progress fighting cancer inch-by-inch, but it’s progress nonetheless. Now’s the time to increase our investment in preventing, diagnosing and treating all kinds of cancer, and not by micro-percentages. Let’s raise priority for the most lethal tumor types such as pancreatic and liver cancers, as well as thoroughly examine why disparities exist in cancer incidence and outcomes among different populations.

With the ACS’s Cancer Facts and Figures 2008 in hand, now would also be a good time for Presidential and Congressional candidates to agree to stop bashing the pharmaceutical industry and instead develop more productive and hopeful messages about the importance of encouraging innovation in cancer diagnosis and treatment among the public and private sectors.

If it works, support it. And more than three-hundredths of one percent annually, please!

-John Seng, Founder and President

, , , , , , ,

A Declaration of Independence

July 4th, 2007

They’re dropping like flies. Independent healthcare PR agencies, that is. What happened? Was it a spring of discontent, a little gastric upset in the constitution? Perhaps a diet not rich enough?

Starting with Chamberlain Communications Group in February this year, then Dorland Health in March; next the UK’s Santé Communications in June; to just last week the granddaddy of Rx indies, Chandler Chicco Agency, an unusually hefty crop of leading health agencies has been harvested by international, conglomerate holding companies.

I’ve weathered takeovers earlier in my career, working for health groups that had sold to Shandwick, WPP and the organization then called DMB&B (D’Arcy, McManus, Benton & Bowles), now part of Publicis Groupe.

It wasn’t always pretty for the people at these firms. I can’t say that client work and people didn’t suffer, because they did.

Not long after the DMB&B deal 12 years ago, I left that organization to launch Spectrum Science Communications. Today, Spectrum ranks as one of the top three independent health only public relations firms in the US. We also stand as the largest health care communications operation in the nation’s capital.

Each of the above former counterpart agencies once proclaimed the virtues of independence: greater focus on their people and their clients in ways they knew that only an O&O (owned and operated) operation could. Forsaking the O&O world, the newly adopted firms are just beginning to experience joys of the E-O, or earn-out. As they now begin to tout the benefits of being owned by somebody else.

The price tag for CCA, $65 million, doesn’t sound like a lot of money – it is a lot of money! But people at a recently acquired firm who think that their new landlord has wheeled in a barrow of cash to liquidate the former owners and invest in the new firm had better think again. That’s not the way that E-Os work. Most of the money paid in the earn-out flows not from Fleet Street or Wall Street financiers but sits on paper, waiting to be squeezed out of ever-greater efficiencies from employees and clients.

Bear in mind that cost-effectiveness for the new owner doesn’t necessarily confer benefits to the acquired agency’s current staff or clients. From my experience, efficiency ala E-Os equals grinding increased revenues out of fewer, cheaper workers toiling longer hours for more clients. The formula works, but only particularly well for the new owner. Hoping the stock price grows as they’ve just augmented the holding company’s bottom line, the new owners bank on riding a tide of current and hopefully growing revenues. Employees caught up in the shift best like it or lump it, those who aren’t laid off during the early belt-tightening. By the time clients discover their agency people and results are waning, it’s often late in the game. Account people get the blame, are fired or quit in frustration, and are soon replaced by a steady and willing supply of fresh-faced juniors.

Independence mattered when these other firms were independent. It was a mark of distinction, a selling-point in their press releases. Now, some firms claim that they’ll remain autonomous and that the new owners won’t meddle in operations. That sounds nice and could be true in the near term, but only during the E-O period if at all. The pressure on continued growth for the holding company and its share price will mandate the kind of economies that can’t help but creep beyond core administrative functions (HR, accounting, office management) into client services and staff compensation.

What I find amusing with each of these recent acquisitions is how the new ownership claims that current clients will benefit from “synergies” and allied or integrated services from the other various companies already in the fold. But in the next breath company principals hasten to explain how no conflicts will exist because sibling companies under the same umbrella parent, and oftentimes same address, can maintain firewalls. In my book, you can’t have it both ways. It’s all about the people. For instance, a team in place representing a breast cancer therapy at the acquired firm encounters a conflict of interest if the acquiring firm works for another pharmaceutical marketer in the same category. Where does synergy cease and conflict begin in a given therapeutic category? More likely, it’s cloudy at best and the only referees are on the payroll.

Independent communications firms offer clients a real choice and value, too. In the good old days when General Motors sat atop the auto industry, no savvy consumer really thought he or she was comparing different choices by kicking the tires at Chevrolet, Buick or Pontiac dealerships, all selling GM brands. What incentive motivates a company to undercut the competition in a scenario in which there are few bona fide competitors? The same is true in shopping for public relations services, especially now in the health care communications domain.

Clients should closely investigate current ownership, potential conflicts and real value before they continue with or assign new work to their PR firms. Corporate strategic sourcing and product managers should carefully examine these types of acquisitions and ask tough questions. Make choices, but carefully qualify the choices.

The plan at Spectrum Science Communications is based on a pledge to remain independent, dedicated to our clients and staff, and committed to extensive and fruitful relations with each. I believe that independence makes a difference, naturally.

-John Seng, Founder and President

, ,

Failure to Thrive

May 29th, 2007
Christopher Lee in the Monday, 28 May 2007 WASHINGTON POST sounds a jarring wake-up call to the impending tragedy of reduced federal funding of the National Institutes of Health.

If Americans already know about these cutbacks facing researchers in cancer, Alzheimer’s, heart disease and mental health and other diseases, we certainly don’t comprehend the looming disaster in human and economic costs. If we did, we’d express some outrage.

I love Mr. Lee’s quote from Rep. David R. Obey (D-Wis.), chairman of the House Appropriations Committee: “Healthy people are a whole lot more productive than sick ones.”

My guess is that healthy people account for more votes, too. We shall see.

- John Seng , , , , , , , ,

Asking a Favor

May 16th, 2007
Diabetes is approaching epidemic proportions in the U.S., and I would appreciate your help in doing something about it.

I have formed a team and am riding my road bike in the Tour de Cure, an important fund-raising event of the American Diabetes Association. I could really use your help - please either 1) join or 2) support our team.

DATE - Sunday, June 10, 2007
LOCATION - Reston, VA, Town Center


The Tour is a ride, not a race, with routes designed for everyone from the occasional rider to the experienced cyclist. Thousands of individual riders and teams have participated to support the Association’s mission: to prevent and cure diabetes and to improve the lives of all people affected by diabetes.

For the fourth consecutive year, we are organizing a team called “Spokes-Persons.” How clever is that?

We can make a difference in the lives of the nearly 21 million Americans suffering from this deadly disease. Rain or shine, it will be a beautiful day.

Please click the link below to register for the Tour de Cure and join or support our team.

Thanks,
John

PS: EVERYONE knows someone with diabetes. Please forward this blog post to your other family members or friends, and ask them to join or help us!

Click here to visit my personal page.

Click here to view the team page for “Spokes” Persons , , , , , , , ,

Fateful New Definition of Cutting Edge Research

May 9th, 2007
I recently joined a group of pancreatic cancer research advocates organized by PanCAN (www.pancan.org) to lobby for increased funding for NIH, not cutbacks as are happening right now. As you read this, researchers are being told to shave the number of patients being studied to save on expenses.

When will elected officials consider the renewal and increase of federal investment in cancer clinical trials as sacrosanct as further limits on gun control.

If most cancer survivors and their families and friends knew that Uncle Sam has taken a paring knife to cancer clinical trials, it’s hard to imagine the outrage. Pass it along, and send a message to your Members of Congress (Representatives, Senators) while you’re at it!

John Seng, , , ,

Citizen Journalism or Free Advertising?

April 20th, 2007
This week the Chicago Tribune will join the brave new world of community-generated journalism by launching www.Triblocal.com – a site which allows readers to publish their own stories, write blogs and cover the “hyper-local” news that might otherwise be missed. Chicago is one of many cities across the nation that’s letting readers take control of newspaper content in this largely unedited and self policed forum. Pieces will be posted on Triblocal.com, but once a week, the best pieces will also be published in a supplement that will be sent out along with the Tribune. Considering the events earlier this week where “citizen journalists” led the newsgathering during the Virginia Tech rampage, the move is not surprising. Newspapers are barely holding on financially with circulation and ad revenue flowing to the internet, and sites like MySpace.com are convincing publishers that they have to experiment if they want to keep readers. Sites like Triblocal.com and Yourhub.com in Denver and other cities will provide a worthwhile experiment to see if you can keep readers by giving them a say in the content of their newspapers. It will be interesting to see whether these sites turn out to be more about free advertising than enterprising journalism. Then again, as one editor put it, “This is a whole different view of what can be news. It’s the very local feeling of a town square. Everything is news in the town square.” M. Weintraub Public Relations, , , , , , , , ,